Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Sofine A"'
Autor:
Anna Kathrine Danielsen, Anne Sofie Frølunde, Sofine Heilskov, Mette Deleuran, Janus Laust Thomsen, Christian Vestergaard
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 4, Pp 1005-1015 (2024)
Abstract Background Patients with atopic dermatitis (AD) are mostly managed by general practitioners (GPs) and practicing dermatologists (PDs) in Denmark. In cases of severe and refractory AD, the primary physician can refer the patient to a speciali
Externí odkaz:
https://doaj.org/article/fe5cfdfdf93a4a62962744b67ce51af8
Autor:
Malthe A. K. Wiis, Sofine Heilskov, Jennifer A. Sørensen, Karen Bang, Henrik Egekvist, Mette Deleuran, Jacob P. Thyssen, Simon F. Thomsen, Christian Vestergaard
Publikováno v:
JEADV Clinical Practice, Vol 1, Iss 3, Pp 288-298 (2022)
Abstract Background Atopic dermatitis (AD) and chronic spontaneous urticaria (CSU) are two prevalent, visible and itching skin diseases associated with decreased quality of life (QoL), sleep disturbance, depression and anxiety. However, little is kno
Externí odkaz:
https://doaj.org/article/1c5ca0758ee040a8b81cc150b427bcf7
Autor:
Wiuff, Anne Christine, Knudsgaard Wiis, Malthe Alexander, Heilskov, Sofine, Frølunde, Anne Sofie, Sørensen, Jennifer Astrup, Deleuran, Mette, Thomsen, Simon Francis, Vestergaard, Christian
Publikováno v:
In World Allergy Organization Journal December 2022 15(12)
Autor:
Danielsen, Anna Kathrine, Frølunde, Anne Sofie, Heilskov, Sofine, Deleuran, Mette, Laust Thomsen, Janus, Vestergaard, Christian
Publikováno v:
JEADV Clinical Practice; Sep2024, Vol. 3 Issue 4, p1005-1015, 11p
Autor:
Anne Christine Wiuff, MBBS, Malthe Alexander Knudsgaard Wiis, MBBS, Sofine Heilskov, MD, Anne Sofie Frølunde, MD, Jennifer Astrup Sørensen, MD, Mette Deleuran, MD, DMSc, Simon Francis Thomsen, MD, PhD, DMSc, Christian Vestergaard, MD, PhD, DMSc
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 12, Pp 100725- (2022)
Background: Patients suffering from Chronic Spontaneous Urticaria (CSU) may be recalcitrant to treatment with high dose second-generation antihistamines. These patients are, according to international guidelines, eligible to treatment with omalizumab
Externí odkaz:
https://doaj.org/article/b27f7204e6fe4bc280fcbc686aa96415
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Mental Illness, Vol 10, Iss 2 (2018)
Capgras Syndrome is a subcategory of delusional disorder. People affected by this syndrome believe that a close associate such as a friend or family member has been replaced by an identical imposter. This case report describes a 23-year-old woman wit
Externí odkaz:
https://doaj.org/article/1d57c999974e4ff3987c8f2a8954ebff
Autor:
Heilskov, Sofine1 (AUTHOR), Deleuran, Mette S.1 (AUTHOR), Vestergaard, Christian1 (AUTHOR) chrivest@rm.dk
Publikováno v:
Dermatology & Therapy. Dec2020, Vol. 10 Issue 6, p1215-1228. 14p.
Publikováno v:
Heilskov, S, Deleuran, M S & Vestergaard, C 2020, ' Immunosuppressive and Immunomodulating Therapy for Atopic Dermatitis in Pregnancy : An Appraisal of the Literature ', Dermatology and therapy, vol. 10, no. 6, pp. 1215-1228 . https://doi.org/10.1007/s13555-020-00457-w
Dermatology and Therapy
Dermatology and Therapy
The aim of this appraisal of the literature is to elucidate the effects of immunosuppressive and immunomodulating agents used to treat atopic dermatitis (AD) on risk factors for fertility, pregnancy, and breastfeeding. Negative side effects of the ps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::743bfa0f17e55f4ba76957a2683f4eaf
https://pure.au.dk/portal/da/publications/immunosuppressive-and-immunomodulating-therapy-for-atopic-dermatitis-in-pregnancy(f7f5b555-e423-4086-9397-e1f1d8882d0c).html
https://pure.au.dk/portal/da/publications/immunosuppressive-and-immunomodulating-therapy-for-atopic-dermatitis-in-pregnancy(f7f5b555-e423-4086-9397-e1f1d8882d0c).html
Publikováno v:
ResearcherID
Future networks (5G and beyond) will demand provisioning of novel services with a varied range of service requirements, and an order of magnitude increase of wireless data traffic, while at the same time decreasing the network operation cost. To addr